— Know what they know.
Not Investment Advice
Also trades as: 0J6Z.L (LSE) · $vol 1M

HUM NYSE

Humana Inc.
1W: +0.8% 1M: +39.6% 3M: +59.9% YTD: +14.8% 1Y: +19.8% 3Y: -39.8% 5Y: -30.1%
$307.95
+4.27 (+1.41%)
 
Weekly Expected Move ±7.5%
$260 $282 $305 $328 $351
NYSE · Healthcare · Medical - Healthcare Plans · Alpha Radar Buy · Power 73 · $37.0B mcap · 120M float · 1.51% daily turnover · Short 66% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

WEAK EDGE
45.9 / 100
NoneWeakNarrowWide
Primary source: Efficient Scale  ·  ROIC: 4.4%  ·  5Y Avg: 11.6%
Cost Advantage
57
Intangibles
35
Switching Cost
40
Network Effect
40
Scale ★
65
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. HUM shows a Weak competitive edge (45.9/100) — limited structural advantages that may face competitive pressure. The primary source of advantage is Efficient Scale. ROIC of 4.4% suggests modest returns relative to capital deployed.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$180
Low
$273
Avg Target
$441
High
Based on 13 analysts since Apr 29, 2026 earnings
Analyst Recommendations
Strong Buy: 0Buy: 14Hold: 28Sell: 2Strong Sell: 0
Rating Summary
ConsensusHold
Avg Target$266.80
Analysts15
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-05-22 UBS $262 $320 +58 +5.4% $303.68
2026-05-20 Mizuho Securities $258 $335 +77 +7.9% $310.55
2026-05-20 Deutsche Bank $235 $441 +206 +42.0% $310.55
2026-05-15 Morgan Stanley Erin Wright $146 $217 +71 -28.0% $301.35
2026-05-13 Piper Sandler $274 $254 -20 -14.0% $295.35
2026-05-01 Raymond James $201 $260 +59 +10.0% $236.44
2026-04-30 RBC Capital Ben Hendrix $189 $246 +57 +2.1% $240.92
2026-04-30 Deutsche Bank $180 $235 +55 -2.5% $241.10
2026-04-30 Oppenheimer $250 $260 +10 +7.1% $242.68
2026-04-30 Truist Financial David MacDonald $200 $270 +70 +11.1% $243.12
2026-04-30 Guggenheim $252 $269 +17 +10.6% $243.12
2026-04-30 UBS $195 $262 +67 +7.8% $243.12
2026-04-30 Barclays $234 $180 -54 -26.0% $243.12
2026-04-08 Evercore ISI Initiated $195 -1.7% $198.39
2026-04-08 Mizuho Securities $345 $258 -87 +30.0% $198.39
2026-02-18 Wells Fargo $290 $206 -84 +11.4% $184.99
2026-02-17 Truist Financial $285 $200 -85 +7.9% $185.36
2026-02-13 Deutsche Bank George Hill $248 $180 -68 -1.6% $182.87
2026-02-12 UBS $620 $195 -425 +10.6% $176.24
2026-02-12 Raymond James Sarah James Initiated $201 +13.1% $177.74
2026-02-12 Oppenheimer $400 $250 -150 +43.8% $173.81
2026-02-12 Morgan Stanley $174 $146 -28 -16.8% $175.40
2026-02-12 Guggenheim Initiated $252 +43.7% $175.40
2026-02-12 RBC Capital Ben Hendrix $265 $189 -76 +7.8% $175.40
2026-02-02 Morgan Stanley $262 $174 -88 -10.9% $195.20
2026-01-07 Wells Fargo $347 $290 -57 +3.6% $279.84
2026-01-06 Bernstein Initiated $344 +22.4% $281.03
2025-12-18 Morgan Stanley Erin Wright $494 $262 -232 +0.7% $260.28
2025-12-05 Jefferies David Windley $253 $313 +60 +23.7% $253.02
2025-11-25 Barclays Andrew Mok $245 $234 -11 +2.1% $229.20
2025-11-10 Truist Financial $300 $285 -15 +17.4% $242.75
2025-10-14 Truist Financial $280 $300 +20 +12.4% $266.92
2025-10-14 Goldman Sachs Scott Fidel $652 $235 -417 -13.3% $271.00
2025-10-09 Mizuho Securities Ann Hynes $300 $345 +45 +15.8% $298.04
2025-10-07 Wells Fargo $348 $347 -1 +17.5% $295.20
2025-10-03 Mizuho Securities $615 $300 -315 +16.9% $256.62
2025-10-03 Barclays $315 $245 -70 -4.5% $256.62
2025-09-04 Barclays Andrew Mok $325 $315 -10 +1.0% $312.00
2025-09-04 Barclays Andrew Mok $275 $325 +50 +4.2% $311.98
2025-07-31 Barclays Andrew Mok $268 $275 +7 +5.2% $261.47
2025-07-18 Wells Fargo Stephen Baxter $514 $348 -166 +60.3% $217.14
2025-06-17 Truist Financial David MacDonald $400 $280 -120 +16.0% $241.45
2025-06-12 Barclays Andrew Mok $250 $268 +18 +14.1% $234.96
2024-12-04 Deutsche Bank George Hill $250 $248 -2 -13.8% $287.64
2024-10-22 Deutsche Bank George Hill Initiated $250 -4.1% $260.57
2024-10-10 Barclays Andrew Mok $370 $250 -120 +1.9% $245.45
2024-10-08 RBC Capital Ben Hendrix $400 $265 -135 +12.2% $236.29
2024-10-07 Jefferies David Windley $419 $253 -166 +5.4% $240.03
2024-10-03 Piper Sandler Jessica Tassan $392 $274 -118 +14.5% $239.32
2024-10-02 Bank of America Securities Kevin Fischbeck $530 $247 -283 +0.2% $246.49

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

B+
May 22, 2026
DCF
5
ROE
3
ROA
4
D/E
1
P/E
2
P/B
4
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. HUM receives an overall rating of B+. Strongest factors: DCF (5/5), ROA (4/5), P/B (4/5). Areas of concern: D/E (1/5), P/E (2/5).
Rating Change History
DateFromTo
2026-05-14 A- B+
2026-04-29 B+ A-
2026-03-12 B B+
2026-01-03 B+ B

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

46 Grade B
Profitability
17
Balance Sheet
48
Earnings Quality
95
Growth
32
Value
67
Momentum
63
Safety
100
Cash Flow
37
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. HUM scores highest in Safety (100/100) and lowest in Profitability (17/100). A grade of B indicates above-average fundamentals with room for improvement in select areas.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
4.12
Safe Zone
Piotroski F-Score
6/9
Beneish M-Score
0.59
Possible Manipulator
Ohlson O-Score
-7.37
Bankruptcy prob: 0.1%
Low Risk
Credit Rating
BBB
Score: 58.1/100
Trend: Deteriorating
Earnings Quality
100/100
OCF/NI: 1.63x
Accruals: -1.5%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. HUM scores 4.12, placing it in the Safe Zone (safe > 2.99, distress < 1.81). Bankruptcy is statistically unlikely within the next two years. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. HUM scores 6/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. HUM's score of 0.59 exceeds the −1.78 red flag threshold — this does not confirm manipulation but indicates the earnings profile resembles past manipulators statistically. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. HUM's implied 0.1% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. HUM receives an estimated rating of BBB (score: 58.1/100), with a deteriorating trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). HUM's score of 100/100 is high — cash flows strongly support reported earnings.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
32.79x
PEG
-0.97x
P/S
0.27x
P/B
1.99x
P/FCF
16.45x
P/OCF
11.34x
EV/EBITDA
10.33x
EV/Revenue
0.22x
EV/EBIT
14.35x
EV/FCF
23.32x
Earnings Yield
5.40%
FCF Yield
6.08%
Shareholder Yield
3.24%
Graham Number
$175.61
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 32.8x earnings, HUM commands a growth premium. An earnings yield of 5.4% exceeds typical risk-free rates, suggesting equities are being compensated for risk. Graham's intrinsic value formula yields $175.61 per share, 75% below the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.816
NI / EBT
×
Interest Burden
0.670
EBT / EBIT
×
EBIT Margin
0.015
EBIT / Rev
×
Asset Turnover
2.881
Rev / Assets
×
Equity Multiplier
2.798
Assets / Equity
=
ROE
6.6%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. HUM's ROE of 6.6% is driven by Asset Turnover (2.881), indicating efficient use of assets to generate revenue.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
$79.61
Price/Value
2.18x
Margin of Safety
-117.80%
Premium
117.80%
Assessment
Overvalued
Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with HUM's realized 0.0% 3-year EPS CAGR — what the company actually delivered, not what analysts hope for. HUM trades at a 118% premium to its adjusted intrinsic value of $79.61, suggesting the market is pricing in future growth beyond what historical earnings support. The adjusted fair P/E of 8.5x compares to the current market P/E of 32.8x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$307.69
Median 1Y
$294.92
5th Pctile
$161.10
95th Pctile
$539.07
Ann. Volatility
38.5%
Analyst Target
$266.80
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Celeste M. Mellet
Chief Financial Officer
$900,000 $10,651,166 $18,922,704
James A. Rechtin
President and Chief Executive Officer
$1,348,558 $13,868,141 $18,757,075
Japan A. Mehta
Chief Information Officer
$618,750 $3,908,903 $9,564,563
Michelle A. O’Hara
Chief Human Resources Officer
$715,385 $4,863,176 $8,942,638
Sanjay K. Shetty,
M.D. President, CenterWell
$715,769 $5,063,055 $7,155,679
Susan M. Diamond
Former Chief Financial Officer
$961,075 $— $2,382,930

CEO Pay Ratio

Insufficient data for pay ratio.

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
67,060
+2.1% YoY
Revenue / Employee
$1,933,552
Rev: $129,664,000,000
Profit / Employee
$17,715
NI: $1,188,000,000
SGA / Employee
Avg labor cost proxy

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
ROE 19.3% 20.7% 19.7% 20.4% 21.1% 18.8% 17.9% 19.8% 21.5% 19.2% 15.8% 12.6% 10.8% 8.6% 7.4% 10.5% 9.7% 7.9% 7.0% 6.6% 6.64%
ROA 7.8% 8.3% 7.4% 7.7% 7.9% 7.1% 6.4% 7.1% 7.7% 6.9% 5.5% 4.4% 3.8% 3.0% 2.6% 3.7% 3.4% 2.8% 2.5% 2.4% 2.37%
ROIC 15.9% 17.2% 12.4% 12.9% 13.5% 12.1% 14.5% 16.2% 17.6% 15.8% 11.6% 9.3% 8.1% 6.5% 5.1% 7.2% 6.6% 5.5% 4.8% 4.4% 4.40%
ROCE 9.6% 9.3% 8.3% 8.8% 9.7% 8.9% 9.2% 10.2% 10.6% 10.1% 8.2% 7.1% 6.4% 5.6% 5.1% 6.6% 6.2% 5.0% 5.6% 5.4% 5.38%
Gross Margin 1.0% 1.0% 1.0% 1.0% 1.0% 1.0% 1.0% 1.0% 1.0% 1.0% 1.0% 1.0% 1.0% 1.0% 1.0% 1.0% 1.0% 14.3% 11.7% 15.0% 14.98%
Operating Margin 3.6% 7.9% -0.3% 5.1% 4.7% 5.7% -0.3% 6.0% 4.7% 4.2% -2.2% 3.4% 3.1% 2.2% -3.0% 5.3% 2.3% 0.3% -3.2% 4.0% 3.98%
Net Margin 2.8% 7.4% -0.1% 3.9% 2.9% 5.2% -0.1% 4.6% 3.6% 3.1% -2.0% 2.5% 2.3% 1.6% -2.4% 3.9% 1.7% 0.6% -2.4% 3.0% 2.99%
EBITDA Margin 4.8% 9.2% 1.1% 6.3% 6.1% 7.1% 1.1% 7.3% 6.0% 5.5% -0.8% 4.8% 4.5% 3.6% -1.6% 6.4% 3.4% 1.5% -2.1% 5.0% 4.96%
FCF Margin 0.6% 1.7% 1.1% 2.4% 3.1% 9.2% 3.7% 10.4% 12.3% 4.9% 2.8% -3.0% -4.5% -3.8% 2.0% 2.0% 2.0% 1.2% 0.3% 0.9% 0.93%
OCF Margin 2.0% 3.3% 2.7% 3.9% 4.5% 10.5% 4.9% 11.5% 13.4% 5.9% 3.7% -2.1% -3.8% -3.2% 2.5% 2.4% 2.4% 1.6% 0.7% 1.3% 1.34%
ROE 3Y Avg snapshot only 9.70%
ROE 5Y Avg snapshot only 13.66%
ROA 3Y Avg snapshot only 3.41%
ROIC 3Y Avg snapshot only 6.52%
ROIC Economic snapshot only 4.17%
Cash ROA snapshot only 3.78%
Cash ROIC snapshot only 6.99%
CROIC snapshot only 4.82%
NOPAT Margin snapshot only 0.85%
Pretax Margin snapshot only 1.01%
R&D / Revenue snapshot only 0.00%
SGA / Revenue snapshot only 0.00%
SBC / Revenue snapshot only 0.18%
Valuation
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
P/E Ratio 22.19 18.13 19.62 17.66 18.32 21.35 22.27 19.04 16.14 19.54 22.04 20.72 25.91 27.76 25.12 18.55 18.67 24.34 25.94 18.51 32.793
P/S Ratio 0.68 0.60 0.69 0.62 0.64 0.65 0.67 0.62 0.55 0.58 0.52 0.38 0.40 0.33 0.26 0.26 0.24 0.25 0.24 0.15 0.269
P/B Ratio 4.01 3.53 3.58 3.33 3.58 3.73 4.08 3.87 3.56 3.85 3.37 2.54 2.73 2.32 1.85 1.94 1.80 1.92 1.75 1.18 1.994
P/FCF 120.79 34.61 60.84 25.78 21.10 7.15 18.03 5.98 4.49 11.76 18.43 -12.73 -8.77 -8.68 12.68 13.32 12.06 20.31 82.19 16.45 16.446
P/OCF 33.98 18.35 25.44 15.76 14.40 6.23 13.62 5.41 4.13 9.84 13.78 10.22 11.04 10.03 15.37 33.47 11.34 11.345
EV/EBITDA 14.02 12.64 14.73 13.12 12.75 14.02 13.81 12.07 10.79 11.97 12.60 10.97 12.51 12.01 11.72 10.16 10.14 12.62 13.32 10.33 10.333
EV/Revenue 0.70 0.61 0.78 0.70 0.72 0.73 0.72 0.66 0.59 0.61 0.57 0.43 0.45 0.38 0.33 0.34 0.31 0.32 0.31 0.22 0.216
EV/EBIT 16.76 15.27 17.58 15.65 15.10 16.92 16.75 14.43 12.87 14.43 15.58 14.08 16.48 16.42 16.48 13.29 13.35 17.34 18.43 14.35 14.348
EV/FCF 123.83 35.60 68.39 29.21 23.72 8.00 19.17 6.38 4.81 12.55 20.28 -14.43 -9.86 -9.95 16.41 17.07 15.72 26.08 105.49 23.32 23.315
Earnings Yield 4.5% 5.5% 5.1% 5.7% 5.5% 4.7% 4.5% 5.3% 6.2% 5.1% 4.5% 4.8% 3.9% 3.6% 4.0% 5.4% 5.4% 4.1% 3.9% 5.4% 5.40%
FCF Yield 0.8% 2.9% 1.6% 3.9% 4.7% 14.0% 5.5% 16.7% 22.3% 8.5% 5.4% -7.9% -11.4% -11.5% 7.9% 7.5% 8.3% 4.9% 1.2% 6.1% 6.08%
Price/Tangible Book snapshot only 3.057
EV/OCF snapshot only 16.083
EV/Gross Profit snapshot only 0.634
Acquirers Multiple snapshot only 21.138
Shareholder Yield snapshot only 3.24%
Graham Number snapshot only $175.61
Leverage & Solvency
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Current Ratio 0.72 0.72 0.724
Quick Ratio 0.72 0.72 0.724
Debt/Equity 0.44 0.44 0.66 0.66 0.66 0.66 0.59 0.59 0.59 0.59 0.63 0.63 0.63 0.63 0.68 0.68 0.68 0.68 0.73 0.73 0.733
Net Debt/Equity 0.10 0.10 0.44 0.44 0.44 0.44 0.26 0.26 0.26 0.26 0.34 0.34 0.34 0.34 0.54 0.54 0.54 0.54 0.49 0.49 0.495
Debt/Assets 0.17 0.17 0.24 0.24 0.24 0.24 0.21 0.21 0.21 0.21 0.22 0.22 0.22 0.22 0.24 0.24 0.24 0.24 0.27 0.27 0.265
Debt/EBITDA 1.50 1.54 2.40 2.28 2.08 2.20 1.88 1.72 1.67 1.72 2.13 2.40 2.56 2.84 3.33 2.79 2.95 3.49 4.36 4.51 4.508
Net Debt/EBITDA 0.34 0.35 1.63 1.54 1.41 1.49 0.83 0.76 0.73 0.76 1.15 1.29 1.39 1.53 2.66 2.23 2.36 2.79 2.94 3.04 3.044
Interest Coverage 11.46 10.63 11.29 11.16 11.59 10.32 9.90 10.34 10.26 9.58 7.86 6.16 5.16 4.10 3.61 4.63 4.42 3.59 3.40 3.11 3.113
Equity Multiplier 2.55 2.55 2.76 2.76 2.76 2.76 2.81 2.81 2.81 2.81 2.89 2.89 2.89 2.89 2.84 2.84 2.84 2.84 2.76 2.76 2.761
Cash Ratio snapshot only 0.407
Debt Service Coverage snapshot only 4.322
Cash to Debt snapshot only 0.325
FCF to Debt snapshot only 0.098
Defensive Interval snapshot only 60.1 days
Efficiency & Turnover
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Asset Turnover 2.51 2.53 2.09 2.18 2.25 2.31 2.12 2.19 2.26 2.34 2.36 2.42 2.49 2.55 2.52 2.57 2.63 2.70 2.72 2.88 2.881
Inventory Turnover
Receivables Turnover 73.34 73.90 56.28 58.51 60.56 61.98 53.25 54.84 56.61 58.69 57.36 58.91 60.41 62.02 49.70 50.75 51.96 53.33 43.41 45.93 45.932
Payables Turnover 11.56 18.44 18.438
DSO 5 5 6 6 6 6 7 7 6 6 6 6 6 6 7 7 7 7 8 8 7.9 days
DIO 0 0 0 0.0 days
DPO 0 32 20 19.8 days
Cash Conversion Cycle 7 -23 -12 -11.8 days
Fixed Asset Turnover snapshot only 50.515
Cash Velocity snapshot only 32.667
Capital Intensity snapshot only 0.355
Growth (YoY)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 14.0% 9.0% 7.7% 9.5% 11.1% 12.8% 11.8% 10.7% 10.5% 11.9% 14.5% 14.2% 13.5% 12.4% 10.7% 10.1% 9.9% 9.9% 10.1% 14.1% 14.08%
Net Income -29.1% -35.6% -12.9% -18.5% 26.6% 5.0% -4.3% 2.6% 7.5% 7.4% -11.3% -36.1% -49.3% -54.9% -51.5% -14.1% -7.9% -5.0% -1.6% -33.9% -33.92%
EPS -27.1% -33.7% -10.5% -17.1% 28.9% 6.6% -2.1% 4.2% 9.2% 10.3% -9.0% -33.8% -47.5% -53.7% -50.8% -13.8% -8.0% -5.0% -1.2% -33.9% -33.86%
FCF -91.9% -71.8% -79.8% -36.3% 5.0% 5.0% 2.7% 3.8% 3.5% -40.3% -14.1% -1.3% -1.4% -1.9% -19.7% 1.7% 1.5% 1.4% -84.3% -46.6% -46.58%
EBITDA -28.5% -39.5% -20.1% -20.9% 26.0% 21.4% 9.6% 13.2% 6.8% 9.8% -0.4% -18.7% -26.5% -31.5% -30.1% -6.2% -5.1% -11.2% -11.3% -28.2% -28.25%
Op. Income -35.7% -47.7% -27.1% -28.2% 27.4% 21.1% 6.4% 12.1% 4.7% 9.1% -5.2% -29.8% -40.5% -49.0% -49.1% -13.8% -8.9% -15.8% -12.0% -41.5% -41.49%
OCF Growth snapshot only -35.84%
Asset Growth snapshot only 4.89%
Equity Growth snapshot only 7.83%
Debt Growth snapshot only 16.09%
Shares Change snapshot only -0.09%
Dividend Growth snapshot only -0.23%
Growth (CAGR)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 3Y 13.5% 13.2% 13.4% 13.7% 13.8% 13.4% 12.7% 12.2% 11.9% 11.2% 11.3% 11.5% 11.7% 12.4% 12.3% 11.7% 11.3% 11.4% 11.8% 12.8% 12.78%
Revenue 5Y 8.1% 8.1% 8.8% 9.7% 10.7% 11.3% 11.6% 12.0% 12.4% 12.8% 13.3% 13.2% 13.0% 12.9% 12.7% 12.2% 11.8% 11.2% 10.9% 11.7% 11.70%
EPS 3Y 24.8% 23.8% 23.1% 22.6% 10.2% 5.0% 3.2% 8.0% 0.8% -8.0% -7.3% -17.0% -9.6% -18.4% -24.0% -15.9% -19.2% -21.4% -23.8% -27.7% -27.73%
EPS 5Y 24.2% 22.8% 40.9% 19.2% 14.7% 11.5% 5.4% 13.6% 22.3% 17.4% 10.7% 4.9% -5.2% -10.0% -13.2% -6.4% -13.1% -19.3% -17.3% -20.1% -20.08%
Net Income 3Y 22.0% 20.9% 20.3% 20.0% 7.9% 3.3% 1.2% 6.0% -1.2% -10.1% -9.6% -18.8% -11.7% -20.2% -25.6% -17.4% -20.6% -22.8% -24.9% -28.7% -28.68%
Net Income 5Y 20.4% 19.1% 36.7% 15.5% 11.6% 8.5% 2.8% 11.3% 19.8% 14.8% 8.1% 2.5% -7.3% -11.8% -14.9% -8.1% -14.8% -20.8% -18.8% -21.2% -21.21%
EBITDA 3Y 13.3% 11.0% 16.0% 17.4% 7.5% 5.2% 4.1% 7.2% -1.3% -6.9% -4.5% -10.0% -0.4% -3.0% -8.6% -4.8% -9.4% -12.6% -14.9% -18.2% -18.20%
EBITDA 5Y 8.6% 6.1% 14.8% 6.4% 5.9% 5.1% 0.3% 6.7% 14.3% 12.8% 11.2% 8.3% -0.5% -2.6% -4.8% -1.2% -7.7% -13.3% -11.6% -13.3% -13.28%
Gross Profit 3Y 13.5% 13.2% 13.4% 13.7% 13.8% 13.4% 12.7% 12.2% 11.9% 11.2% 11.3% 11.5% 11.7% 12.4% 12.3% 11.7% 11.3% 2.4% -7.7% -21.2% -21.21%
Gross Profit 5Y 8.1% 8.1% 8.8% 9.7% 10.7% 11.3% 11.6% 12.0% 12.4% 12.8% 13.3% 13.2% 13.0% 12.9% 12.7% 12.2% 11.8% 5.7% -1.1% -9.9% -9.92%
Op. Income 3Y 15.1% 11.8% 17.6% 18.9% 5.8% 2.8% 1.1% 5.0% -5.0% -11.6% -9.7% -17.3% -7.4% -12.3% -19.9% -12.1% -17.2% -22.3% -24.8% -29.3% -29.25%
Op. Income 5Y 8.7% 5.3% 16.7% 5.2% 4.5% 3.3% -2.4% 5.5% 15.3% 13.0% 10.4% 5.8% -5.9% -9.6% -13.0% -6.9% -14.2% -21.6% -19.9% -22.2% -22.20%
FCF 3Y -46.3% -15.4% 1.1% 30.7% -8.6% 34.6% 29.2% 0.3% -14.0% 36.2% 4.6% -3.7% -43.1% -52.4% -49.6% -49.58%
FCF 5Y -15.4% -20.9% -7.7% -16.5% -12.5% 17.9% -0.3% 27.1% 32.8% 13.8% -12.1% -10.2% -15.4% -20.8% -39.6% -17.2% -17.19%
OCF 3Y -22.7% 1.3% 61.9% 29.4% -4.6% 31.2% 26.6% 0.7% -11.0% 9.5% -5.5% -9.8% -40.3% -41.4% -44.8% -44.81%
OCF 5Y 0.6% -12.1% 3.2% -9.7% -7.3% 18.1% 2.5% 25.4% 30.3% 12.9% -10.9% -10.0% -14.7% -19.0% -30.4% -15.7% -15.69%
Assets 3Y 8.8% 8.8% 20.4% 20.4% 20.4% 20.4% 14.0% 14.0% 14.0% 14.0% 10.4% 10.4% 10.4% 10.4% 1.6% 1.6% 1.6% 1.6% 4.2% 4.2% 4.23%
Assets 5Y 7.2% 7.2% 11.8% 11.8% 11.8% 11.8% 9.6% 9.6% 9.6% 9.6% 13.1% 13.1% 13.1% 13.1% 9.8% 9.8% 9.8% 9.8% 6.9% 6.9% 6.87%
Equity 3Y 11.7% 11.7% 16.5% 16.5% 16.5% 16.5% 8.3% 8.3% 8.3% 8.3% 5.8% 5.8% 5.8% 5.8% 0.6% 0.6% 0.6% 0.6% 4.9% 4.9% 4.87%
Book Value 3Y 14.3% 14.4% 19.2% 19.1% 19.1% 18.5% 10.5% 10.4% 10.6% 11.0% 8.5% 8.2% 8.3% 8.2% 2.7% 2.4% 2.3% 2.4% 6.4% 6.3% 6.27%
Dividend 3Y 6.1% 5.8% 5.4% 5.1% 5.3% 5.0% 5.5% 5.4% 5.6% 5.8% 5.9% 5.4% 4.3% 3.3% 2.1% 1.0% 1.2% 1.4% 1.4% 1.3% 1.26%
Growth Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue Stability 0.81 0.85 0.88 0.92 0.95 0.97 0.98 0.99 1.00 1.00 0.99 0.99 1.00 1.00 0.99 0.99 0.99 0.99 0.99 0.98 0.981
Earnings Stability 0.65 0.60 0.68 0.77 0.54 0.33 0.34 0.62 0.54 0.18 0.14 0.02 0.08 0.30 0.56 0.47 0.55 0.79 0.90 0.95 0.950
Margin Stability 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 0.90 0.79 0.66 0.661
Rev. Growth Consistency 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Earn. Growth Consistency 0.00 0.00 0.00 0.00 0.50 0.50 0.00 0.50 1.00 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.000
FCF Positive Streak 1 1 1 1 1 1 1 1 1 1 1 0 0 0 1 0 0 0 1 1 0
Earnings Persistence 0.88 0.86 0.95 0.93 0.89 0.98 0.98 0.99 0.97 0.97 0.95 0.86 0.80 0.50 0.50 0.94 0.97 0.98 0.99 0.86 0.864
Earnings Smoothness 0.66 0.57 0.86 0.80 0.76 0.95 0.96 0.97 0.93 0.93 0.88 0.56 0.34 0.24 0.31 0.85 0.92 0.95 0.98 0.59 0.592
ROE Trend -0.09 -0.10 -0.05 -0.06 -0.04 -0.10 -0.03 -0.03 0.03 0.01 -0.03 -0.07 -0.10 -0.10 -0.09 -0.06 -0.07 -0.06 -0.05 -0.05 -0.049
Gross Margin Trend 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.22 -0.44 -0.66 -0.659
FCF Margin Trend -0.04 -0.05 -0.05 -0.03 -0.01 0.05 0.00 0.07 0.11 -0.01 0.00 -0.09 -0.12 -0.11 -0.01 -0.02 -0.02 0.01 -0.02 0.01 0.014
Sustainable Growth Rate 16.6% 18.1% 17.3% 17.9% 18.6% 16.3% 15.4% 17.3% 18.9% 16.5% 13.0% 9.8% 8.1% 5.9% 4.8% 7.8% 7.0% 5.3% 4.5% 4.1% 4.12%
Internal Growth Rate 7.2% 7.8% 7.0% 7.2% 7.5% 6.5% 5.8% 6.6% 7.3% 6.3% 4.8% 3.6% 2.9% 2.1% 1.7% 2.8% 2.5% 1.9% 1.6% 1.5% 1.49%
Cash Flow Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
OCF/Net Income 0.65 0.99 0.77 1.12 1.27 3.43 1.63 3.52 3.90 1.99 1.60 -1.15 -2.48 -2.68 2.46 1.68 1.86 1.58 0.78 1.63 1.632
FCF/OCF 0.28 0.53 0.42 0.61 0.68 0.87 0.76 0.90 0.92 0.84 0.75 1.42 1.19 1.19 0.81 0.83 0.83 0.76 0.41 0.69 0.690
FCF/Net Income snapshot only 1.126
OCF/EBITDA snapshot only 0.643
CapEx/Revenue 1.4% 1.5% 1.6% 1.5% 1.4% 1.3% 1.2% 1.1% 1.0% 1.0% 0.9% 0.9% 0.7% 0.6% 0.5% 0.4% 0.4% 0.4% 0.4% 0.4% 0.42%
CapEx/Depreciation snapshot only 0.712
Accruals Ratio 0.03 0.00 0.02 -0.01 -0.02 -0.17 -0.04 -0.18 -0.22 -0.07 -0.03 0.09 0.13 0.11 -0.04 -0.02 -0.03 -0.02 0.01 -0.01 -0.015
Sloan Accruals snapshot only -0.077
Cash Flow Adequacy snapshot only 1.842
Earnings Quality Score snapshot only 1.000
Dividends & Buybacks
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Dividend Yield 0.6% 0.7% 0.6% 0.7% 0.6% 0.6% 0.6% 0.7% 0.8% 0.7% 0.8% 1.1% 1.0% 1.2% 1.4% 1.4% 1.5% 1.4% 1.4% 2.1% 1.15%
Dividend/Share $2.63 $2.68 $2.75 $2.84 $2.93 $3.00 $3.12 $3.19 $3.29 $3.40 $3.52 $3.63 $3.61 $3.59 $3.57 $3.56 $3.55 $3.55 $3.57 $3.56 $3.54
Payout Ratio 13.7% 13.0% 12.1% 11.9% 11.8% 13.6% 14.0% 12.9% 12.2% 14.0% 17.3% 22.1% 25.5% 31.9% 35.7% 25.1% 27.2% 33.2% 36.2% 38.0% 37.96%
FCF Payout Ratio 74.6% 24.8% 37.4% 17.4% 13.6% 4.6% 11.3% 4.0% 3.4% 8.4% 14.5% 18.0% 18.1% 17.6% 27.7% 1.1% 33.7% 33.73%
Total Payout Ratio 87.3% 81.3% 14.8% 47.3% 46.0% 51.9% 88.7% 50.3% 62.3% 82.5% 80.5% 1.3% 1.3% 1.3% 1.0% 31.5% 37.4% 45.5% 48.9% 60.0% 60.00%
Div. Increase Streak 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 0 0 0 0 0 0
Chowder Number 0.12 0.11 0.10 0.09 0.10 0.11 0.11 0.11 0.12 0.11 0.11 0.11 0.07 0.04 0.01 -0.01 -0.00 0.00 0.01 0.02 0.018
Buyback Yield 3.3% 3.8% 0.1% 2.0% 1.9% 1.8% 3.4% 2.0% 3.1% 3.5% 2.9% 5.3% 3.9% 3.5% 2.7% 0.3% 0.5% 0.5% 0.5% 1.2% 1.19%
Net Buyback Yield 3.3% 3.8% 0.1% 2.0% 1.9% 1.8% 3.4% 2.0% 3.1% 3.5% 2.9% 5.3% 3.9% 3.5% 2.7% 0.3% 0.5% 0.5% 0.5% 1.2% 1.19%
Total Shareholder Return 3.9% 4.5% 0.8% 2.7% 2.5% 2.4% 4.0% 2.6% 3.9% 4.2% 3.7% 6.4% 4.9% 4.7% 4.1% 1.7% 2.0% 1.9% 1.9% 3.2% 3.24%
DuPont Factors
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Tax Burden (NI/EBT) 0.78 0.88 0.86 0.85 0.80 0.79 0.79 0.79 0.83 0.78 0.75 0.73 0.72 0.71 0.74 0.73 0.73 0.80 0.79 0.82 0.816
Interest Burden (EBT/EBIT) 0.94 0.93 0.93 0.92 0.92 0.90 0.90 0.90 0.90 0.89 0.86 0.82 0.78 0.73 0.68 0.76 0.75 0.70 0.70 0.67 0.670
EBIT Margin 0.04 0.04 0.04 0.04 0.05 0.04 0.04 0.05 0.05 0.04 0.04 0.03 0.03 0.02 0.02 0.03 0.02 0.02 0.02 0.02 0.015
Asset Turnover 2.51 2.53 2.09 2.18 2.25 2.31 2.12 2.19 2.26 2.34 2.36 2.42 2.49 2.55 2.52 2.57 2.63 2.70 2.72 2.88 2.881
Equity Multiplier 2.49 2.49 2.66 2.66 2.66 2.66 2.78 2.78 2.78 2.78 2.85 2.85 2.85 2.85 2.87 2.87 2.87 2.87 2.80 2.80 2.798
Per Share
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
EPS (Diluted TTM) $19.18 $20.68 $22.81 $23.81 $24.73 $22.04 $22.33 $24.81 $27.00 $24.32 $20.32 $16.42 $14.18 $11.25 $9.99 $14.16 $13.05 $10.69 $9.87 $9.37 $9.37
Book Value/Share $106.10 $106.21 $125.03 $126.14 $126.53 $126.26 $121.86 $121.94 $122.38 $123.49 $132.79 $134.10 $134.77 $134.66 $135.60 $135.60 $135.62 $135.58 $146.73 $146.35 $154.95
Tangible Book/Share $69.19 $69.26 $18.26 $18.43 $18.48 $18.44 $35.05 $35.07 $35.20 $35.52 $40.98 $41.39 $41.59 $41.56 $43.90 $43.90 $43.90 $43.89 $56.86 $56.72 $56.72
Revenue/Share $621.78 $627.23 $645.85 $677.52 $703.34 $718.34 $739.15 $761.70 $789.13 $825.52 $868.64 $900.84 $928.49 $952.35 $975.13 $995.84 $1019.59 $1046.23 $1077.49 $1137.15 $1140.18
FCF/Share $3.52 $10.83 $7.36 $16.32 $21.47 $65.84 $27.59 $79.04 $97.16 $40.40 $24.31 $-26.73 $-41.88 $-35.97 $19.80 $19.72 $20.20 $12.81 $3.12 $10.54 $10.57
OCF/Share $12.53 $20.43 $17.59 $26.68 $31.48 $75.52 $36.51 $87.38 $105.42 $48.30 $32.51 $-18.83 $-35.19 $-30.14 $24.56 $23.80 $24.28 $16.93 $7.65 $15.28 $15.32
Cash/Share $36.12 $36.15 $26.39 $26.63 $26.71 $26.65 $40.28 $40.31 $40.45 $40.82 $38.33 $38.71 $38.90 $38.87 $18.39 $18.39 $18.39 $18.39 $34.90 $34.81 $182.54
EBITDA/Share $31.13 $30.50 $34.16 $36.34 $39.95 $37.57 $38.31 $41.76 $43.32 $42.38 $39.14 $35.15 $33.02 $29.81 $27.73 $33.12 $31.31 $26.47 $24.68 $23.79 $23.79
Debt/Share $46.84 $46.88 $81.96 $82.69 $82.95 $82.77 $71.90 $71.95 $72.21 $72.86 $83.40 $84.22 $84.64 $84.57 $92.28 $92.28 $92.29 $92.27 $107.50 $107.23 $107.23
Net Debt/Share $10.72 $10.73 $55.57 $56.07 $56.24 $56.12 $31.62 $31.64 $31.76 $32.04 $45.07 $45.51 $45.74 $45.70 $73.89 $73.89 $73.90 $73.88 $72.60 $72.41 $72.41
Academic Models
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Altman Z-Score 4.124
Altman Z-Prime snapshot only 2.555
Piotroski F-Score 5 4 4 5 6 5 5 6 6 6 6 4 4 4 5 5 4 4 5 6 6
Beneish M-Score -2.21 -2.35 -1.67 -1.79 -1.84 -2.46 -2.75 -3.40 -3.61 -2.86 -2.41 -1.84 -1.67 -1.76 -2.38 -2.31 -2.33 0.90 1.68 0.59 0.590
Ohlson O-Score snapshot only -7.370
Net-Net WC snapshot only $-195.13
EVA snapshot only $-1478681069.36
Credit
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Credit Rating snapshot only BBB
Credit Score 79.69 81.12 76.00 79.01 80.24 88.17 85.74 92.43 91.58 88.31 79.29 74.08 73.47 67.05 72.07 71.07 72.28 69.43 57.19 58.14 58.144
Credit Grade snapshot only 9
Credit Trend snapshot only -12.926
Implied Spread (bps) snapshot only 275.000
Industry Credit Rank snapshot only 46
Sector Credit Rank snapshot only 52

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms